1 min read
Add as a preferred source on Google

Johnson & Johnson Discusses Ollin Biosciences Deal Worth Up to $3.4B

An announcement could come as soon as Monday, Nov. 16.

A clear laboratory vessel rests between two separated steel forms / TokenPost.ai
A clear laboratory vessel rests between two separated steel forms / TokenPost.ai

Johnson & Johnson is in talks to acquire privately held Ollin Biosciences for up to $3.4 billion. An announcement could come as soon as Monday, Nov. 16.

The talks concern a potential purchase; no completed acquisition is announced.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…